| Literature DB >> 28011379 |
Mostafa Cheraghi1, Babak Negahdari2, Hadis Daraee3, Ali Eatemadi4.
Abstract
Nanoliposomes are type of nano-sized vesicles made of bi-layered phospholipid membranes with an aqueous interior. They have been demonstrated to deliver several materials like low molecular weight drugs, imaging agents, peptides, proteins, and nucleic acids. Nanoliposomes have been demonstrated to slowly release an encapsulated drug, thereby leading to sustained exposure to target region and improved efficacy. This ability of nano-liposomes can be harnessed to deliver therapeutic agents precisely to the infarcted heart. Accordingly, this article will review recent developments in the application of nano liposomes and nanoparticles as drug delivery systems to treat cardiovascular related disorders such as atherosclerosis, restenosis and myocardial infarction.Entities:
Keywords: Atherosclerosis; Myocardial infarction; Nano-liposomes; Nanoparticles
Mesh:
Substances:
Year: 2016 PMID: 28011379 DOI: 10.1016/j.biopha.2016.12.009
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529